financetom
Business
financetom
/
Business
/
French firms to boost capacity to spy from the stratosphere
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
French firms to boost capacity to spy from the stratosphere
Sep 30, 2025 4:22 AM

*

France has launched a strategy to operate at Very High

Altitude

*

Near-space becoming priority after Chinese balloon

incident

*

Thales Alenia Space developing Stratobus airship

*

Startup Hemeria to stage second test flight of Balman

balloon

By Tim Hepher

PARIS, Sept 30 (Reuters) - French companies are

fine-tuning plans for stratospheric spy balloons and airships as

competition heats up in the no man's land between the atmosphere

and outer space, tipped as the next potential zone of tensions

between world powers.

Stratobus, owned by Thales Alenia Space, and

Hemeria, a small firm created in 2019 to prevent sensitive

technology leaving France during a wider merger, are the latest

companies to focus on a belt known as Very High Altitude.

The growing importance of near-space captured global

attention in 2023 when the United States shot down a suspected

Chinese spy balloon. Beijing insisted it served scientific

purposes and strayed into U.S. airspace accidentally.

"It's a space that's not occupied. We have to be there and

if we aren't, others will be," Stratobus head Yannick Combet

said.

FRENCH COMPANIES TESTING HIGH-ALTITUDE VESSELS

The Stratobus airship is designed to re-establish

communications after a disaster or sit with observation cameras

above an area of sudden interest, like a hostage-taking.

"Notre-Dame (cathedral) would fit inside the balloon," which

is 142 metres long, Combet told the AJPAE media association.

Thales is building test models and aims to be ready for use by

2031.

Hemeria's smaller Balman balloon is designed to get into

position quickly and can manoeuvre by changing altitude to

exploit wind currents.

A second test flight is planned in coming weeks, with

limited operations starting in 2027.

"We want to be reactive and capable of launching in a few

hours... Today the minimum preparation time for such a balloon

is two months," said project manager Alexandre Hulin.

In June, France unveiled a new strategy calling for the

ability to operate at Very High Altitudes between 20 km and 100

km (12.4 and 62 miles) and intercept opponents.

Weeks later, Paris said fighters had downed two balloons

flying more than 20 km above the ground as a demonstration.

REGULATORY GREY ZONE

Officials say such vehicles can intervene over great

distances and then stay over the same spot for months,

complementing constantly-moving satellites.

However, they operate in a legal grey zone left over from

the earliest days of air power and only now getting attention.

After World War One introduced aerial bombing, Paris peace

negotiators granted every nation sovereignty over its airspace,

abandoning efforts to make the skies as open as the high seas.

The right of each country to control its airspace was

confirmed towards the end of World War Two.

Space evolved on opposite lines. A 1967 treaty declared

outer space "free for exploration and use" but negotiators

failed to establish an outer limit for the tapering atmosphere.

Now, the fuzzy boundary between Earth and space is emerging

as a new front of competition.

"The more technology improves, the more we will fly higher

and faster... and the more satellites will orbit lower,"

Brigadier-General Alexis Rougier, France's top official for Very

High Altitudes, said last week.

"So a zone that was little used in the past will be used

more and more," he told the National Assembly defence committee.

(Reporting by Tim Hepher; Editing by Emelia Sithole-Matarise)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coca Cola Insider Sold Shares Worth $3,492,111, According to a Recent SEC Filing
Coca Cola Insider Sold Shares Worth $3,492,111, According to a Recent SEC Filing
Mar 15, 2024
02:07 PM EDT, 03/15/2024 (MT Newswires) -- Nancy Quan, Executive Vice President, on March 13, 2024, sold 57,368 shares in Coca Cola (KO) for $3,492,111. Following the Form 4 filing with the SEC, Quan has control over a total of 228,376 shares of the company, with 223,330 shares held directly and 5,046 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/21344/000112760224010244/xslF345X03/form4.xml Price: 59.91, Change:...
Tesla settles race bias claims by Black former worker after $3 million verdict
Tesla settles race bias claims by Black former worker after $3 million verdict
Mar 15, 2024
(Reuters) - Tesla has settled a long running lawsuit by a Black former factory worker who claimed he was subjected to severe racial harassment, according to a court filing on Friday, as the electric carmaker faces a series of other discrimination lawsuits. Tesla and lawyers for Owen Diaz, a former elevator operator at the company's Fremont, California assembly plant, did...
Even The Untouchable Adobe Is Threatened By Intensified AI Competition
Even The Untouchable Adobe Is Threatened By Intensified AI Competition
Mar 15, 2024
Adobe Inc ( ADBE ) surpassed both top and bottom-line estimates, but shares tumbled 14% on Friday due to a weaker than expected sales outlook. This is Adobe's biggest slump since 2022. The news also pulled down the stock of its industry peer Microsoft Corporation ( MSFT ) . The design software company is benefiting from the AI hype, but this...
Market Chatter: Johnson & Johnson Blood Cancer Therapy Receives FDA Panel Backing
Market Chatter: Johnson & Johnson Blood Cancer Therapy Receives FDA Panel Backing
Mar 15, 2024
02:04 PM EDT, 03/15/2024 (MT Newswires) -- Johnson & Johnson's ( JNJ ) cell therapy, Carvykti, for treating a specific form of blood cancer at an earlier stage got unanimous support for authorization by the advisers to the US Food and Drug Administration, Reuters reported Friday. The 11-member voting panel agreed that the advantages of the therapy outweigh the risks...
Copyright 2023-2026 - www.financetom.com All Rights Reserved